isoproterenol has been researched along with vitexin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, ZM; Hang, PZ; Lu, CC; Qi, JC; Wang, C; Wang, Y; Wu, JC; Wu, JW; Xu, YQ; Zhang, Y | 1 |
| Ashokkumar, R; Jamuna, S; Niranjali Devaraj, S; Sakeena Sadullah, MS | 1 |
2 other study(ies) available for isoproterenol and vitexin
| Article | Year |
|---|---|
Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
Topics: Animals; Animals, Newborn; Apigenin; Calcineurin; Calcineurin Inhibitors; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Isoproterenol; Male; Mice; Myocytes, Cardiac; Pressure; Rats; Rats, Wistar; Signal Transduction | 2013 |
Vitexin protects isoproterenol induced post myocardial injury by modulating hipposignaling and ER stress responses.
Topics: Animals; Antioxidants; Apigenin; Apoptosis; Cardiotonic Agents; Caspase 3; Endoplasmic Reticulum Stress; Isoproterenol; Male; Myocardial Infarction; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Signal Transduction | 2018 |